Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A case report describing the immune response of an infant with congenital heart disease and severe COVID-19.
Wurzel D, Neeland MR, Anderson J, Abo YN, Do LAH, Donato CM, Bines JE, Toh ZQ, Higgins RA, Jalali S, Cole T, Subbarao K, McMinn A, Dohle K, Haeusler GM, McNab S, Alafaci A, Overmars I, Clifford V, Lee LY, Daley AJ, Buttery J, Bryant PA, Burgner D, Steer A, Tosif S, Konstantinov IE, Duke T, Licciardi PV, Pellicci DG, Crawford NW. Wurzel D, et al. Among authors: bines je. Commun Med (Lond). 2021 Nov 15;1:47. doi: 10.1038/s43856-021-00047-7. eCollection 2021. Commun Med (Lond). 2021. PMID: 35602234 Free PMC article.
Optimizing immunization in pediatric special risk groups.
Crawford NW, Bines JE, Royle J, Buttery JP. Crawford NW, et al. Among authors: bines je. Expert Rev Vaccines. 2011 Feb;10(2):175-86. doi: 10.1586/erv.10.157. Expert Rev Vaccines. 2011. PMID: 21332267 Review.
Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine.
Danchin M, Kirkwood CD, Lee KJ, Bishop RF, Watts E, Justice FA, Clifford V, Cowley D, Buttery JP, Bines JE. Danchin M, et al. Among authors: bines je. Vaccine. 2013 May 28;31(23):2610-6. doi: 10.1016/j.vaccine.2013.04.008. Epub 2013 Apr 16. Vaccine. 2013. PMID: 23597719 Clinical Trial.
Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial.
Bines JE, Danchin M, Jackson P, Handley A, Watts E, Lee KJ, West A, Cowley D, Chen MY, Barnes GL, Justice F, Buttery JP, Carlin JB, Bishop RF, Taylor B, Kirkwood CD; RV3 Rotavirus Vaccine Program. Bines JE, et al. Lancet Infect Dis. 2015 Dec;15(12):1389-97. doi: 10.1016/S1473-3099(15)00227-3. Epub 2015 Aug 26. Lancet Infect Dis. 2015. PMID: 26318715 Clinical Trial.
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.
Bines JE, At Thobari J, Satria CD, Handley A, Watts E, Cowley D, Nirwati H, Ackland J, Standish J, Justice F, Byars G, Lee KJ, Barnes GL, Bachtiar NS, Viska Icanervilia A, Boniface K, Bogdanovic-Sakran N, Pavlic D, Bishop RF, Kirkwood CD, Buttery JP, Soenarto Y. Bines JE, et al. N Engl J Med. 2018 Feb 22;378(8):719-730. doi: 10.1056/NEJMoa1706804. N Engl J Med. 2018. PMID: 29466164 Free PMC article. Clinical Trial.
139 results